Literature DB >> 23564385

Molecular virology of hepatitis E virus.

R Prasida Holla1, Imran Ahmad, Zulfazal Ahmad, Shahid Jameel.   

Abstract

Hepatitis E virus (HEV) is the causative agent of hepatitis E. It is a nonenveloped virus with a ∼7.2 kilobases positive-stranded RNA genome. The molecular virology of HEV is getting better understood with the development of replicons and in vitro infection systems, and the discovery of related viruses that infect animal species other than humans. This review focuses on the virology of HEV and updates the current knowledge on the HEV genome and its constituent proteins--ORF1, ORF2, and ORF3, and the viral life cycle. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23564385     DOI: 10.1055/s-0033-1338110

Source DB:  PubMed          Journal:  Semin Liver Dis        ISSN: 0272-8087            Impact factor:   6.115


  54 in total

1.  Potent Inhibition of Hepatitis E Virus Release by a Cyclic Peptide Inhibitor of the Interaction between Viral Open Reading Frame 3 Protein and Host Tumor Susceptibility Gene 101.

Authors:  Saumya Anang; Nidhi Kaushik; Smita Hingane; Anita Kumari; Jyoti Gupta; Shailendra Asthana; Baibaswata Nayak; C T Ranjith-Kumar; Milan Surjit
Journal:  J Virol       Date:  2018-09-26       Impact factor: 5.103

Review 2.  Hepatitis e: epidemiology and natural history.

Authors:  Rakesh Aggarwal
Journal:  J Clin Exp Hepatol       Date:  2013-06-10

3.  Mutation in the Hepatitis E Virus Polymerase and Outcome of Ribavirin Therapy.

Authors:  Sebastien Lhomme; Nassim Kamar; Florence Nicot; Jacques Ducos; Michael Bismuth; Valerie Garrigue; Joelle Petitjean-Lecherbonnier; Isabelle Ollivier; Elodie Alessandri-Gradt; Odile Goria; Heidi Barth; Peggy Perrin; Karine Saune; Martine Dubois; Romain Carcenac; Caroline Lefebvre; Nicolas Jeanne; Florence Abravanel; Jacques Izopet
Journal:  Antimicrob Agents Chemother       Date:  2015-12-28       Impact factor: 5.191

4.  Acute hepatitis E in India appears to be caused exclusively by genotype 1 hepatitis E virus.

Authors:  Neha Gupta; Aditya N Sarangi; Sunil Dadhich; V K Dixit; Kamal Chetri; Amit Goel; Rakesh Aggarwal
Journal:  Indian J Gastroenterol       Date:  2018-02-05

5.  Hepatitis E Virus Genotype 3 Genomes from RNA-Positive but Serologically Negative Plasma Donors Have CUG as the Start Codon for ORF3.

Authors:  Heléne Norder; Cristina Galli; Ellen Magnil; Per Sikora; Elisabet Ekvärn; Kristina Nyström; Lars O Magnius
Journal:  Intervirology       Date:  2018-10-02       Impact factor: 1.763

6.  Characterization of the polyproline region of the hepatitis E virus in immunocompromised patients.

Authors:  Sebastien Lhomme; Florence Abravanel; Martine Dubois; Karine Sandres-Saune; Jean-Michel Mansuy; Lionel Rostaing; Nassim Kamar; Jacques Izopet
Journal:  J Virol       Date:  2014-08-06       Impact factor: 5.103

Review 7.  Hepatitis E virus infection: Epidemiology and treatment implications.

Authors:  Ga Young Lee; Kittiyod Poovorawan; Duangnapa Intharasongkroh; Pattaratida Sa-Nguanmoo; Sompong Vongpunsawad; Chintana Chirathaworn; Yong Poovorawan
Journal:  World J Virol       Date:  2015-11-12

8.  Phylogenetic analysis of two genotype 3 Hepatitis E viruses from wild boar, Italy.

Authors:  Luca De Sabato; Gabriele Vaccari; Philippe Lemey; Maria Grazia Amoroso; Giovanna Fusco; Giovanni Ianiro; Ilaria Di Bartolo
Journal:  Virus Genes       Date:  2018-09-10       Impact factor: 2.332

Review 9.  Open reading frame 3 protein of hepatitis E virus: Multi-function protein with endless potential.

Authors:  Yong-Lin Yang; Yu-Chen Nan
Journal:  World J Gastroenterol       Date:  2021-05-28       Impact factor: 5.742

10.  A tightly clustered hepatitis E virus genotype 1a is associated with endemic and outbreak infections in Bangladesh.

Authors:  Trang Nguyen Hoa; Saif Ullah Munshi; Khanh Nguyen Ngoc; Chau Le Ngoc; Thanh Tran Thi Thanh; Tahmina Akther; Shahina Tabassum; Nilufa Parvin; Stephen Baker; Motiur Rahman
Journal:  PLoS One       Date:  2021-07-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.